Article info

Download PDFPDF
Cost-effectiveness of pravastatin in the secondary prevention of CAD in men varied with the risk profile of the patient

Citation

Cost-effectiveness of pravastatin in the secondary prevention of CAD in men varied with the risk profile of the patient
Online issue publication 
March 28, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.